Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,751 | 23,491 | 22,397 | 54,197 | 4,573 |
| Marketable Securities | 44,872 | 98,948 | 106,823 | 113,178 | N/A |
| TOTAL | $80,117 | $124,232 | $131,496 | $174,333 | $4,676 |
| Non-Current Assets | |||||
| PPE Net | 6 | 288 | 242 | 186 | 39 |
| Other Non-Current Assets | 209 | 2,898 | 3,563 | 844 | 0 |
| TOTAL | $215 | $3,186 | $3,805 | $1,030 | $39 |
| Total Assets | $80,332 | $127,418 | $135,301 | $175,363 | $4,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 224 | 2,396 | 2,575 | 1,208 | 618 |
| Accrued Expenses | 3,187 | 14,821 | 4,822 | 1,150 | 1,156 |
| TOTAL | $3,828 | $17,637 | $7,782 | $2,550 | $1,774 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 70 | 325 | 776 | 395 | 16,285 |
| TOTAL | $70 | $325 | $776 | $395 | $16,285 |
| Total Liabilities | $3,898 | $17,962 | $8,558 | $2,945 | $18,059 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 826 | 794 | 707 | 696 | N/A |
| Common Shares | 3 | 3 | 2 | 2 | N/A |
| Retained earnings | -233,052 | -163,424 | -87,903 | -36,392 | -13,407 |
| Other shareholders' equity | 105 | 237 | -466 | -59 | 0 |
| TOTAL | $76,434 | $109,456 | $126,743 | $172,418 | $-13,344 |
| Total Liabilities And Equity | $80,332 | $127,418 | $135,301 | $175,363 | $4,715 |